Parkinson’s Disease & Multiple Sclerosis

The Parkinson’s Disease & Multiple Sclerosis program provides evidence-informed education on cannabinoid therapeutics and their potential role in supporting people living with neurodegenerative and neurological conditions.

Learners explore how Parkinson’s disease and multiple sclerosis affect the body, including neurodegeneration, disease progression, symptom patterns, and the endocannabinoid system. The program also reviews current research on CBD, THC, and other cannabinoids in relation to symptoms such as pain, spasticity, sleep disruption, mobility challenges, and quality of life.

Practical guidance includes starting-dose considerations, CBD and ratio tinctures, edibles, patches, topicals, routes of administration, medication interactions, product safety, and how to discuss cannabinoid use with healthcare providers.

This program includes:

• A 60+ minute recorded lecture on CBD, cannabis medicine, Parkinson’s disease, and multiple sclerosis
• A downloadable PDF slide deck with presentation references
• A digital guidebook with implementation and safety considerations
• Bonus videos on holistic health and whole-person wellness
• Access to a community forum for continued learning and peer support